Estimate Recalculated Jul 22, 2025 10:34PM EST
David P Bonita does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prelude Therapeutics Inc, SI-BONE, Inc., Repare Therapeutics Inc., ViewRay, Inc., Tricida, Inc., Ikena Oncology, Inc., Loxo Oncology, Inc., Acutus Medical, Inc., IMARA Inc., Third Harmonic Bio, Inc., and AMBIT BIOSCIENCES CORP.
David P Bonita's CIK is 0001572451
2022 was David P Bonita's most active year for acquiring shares with 8 total transactions. David P Bonita's most active month to acquire stocks was the month of May. 2013 was David P Bonita's most active year for disposing of shares, totalling 1 transactions. David P Bonita's most active month to dispose stocks was the month of February. 2021 saw David P Bonita paying a total of $0.00 for 131,548 shares, this is the most they've acquired in one year. In 2023 David P Bonita cashed out on 13,667 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!